Brandon introduces DentalVibe technology for use during procedures involving local anesthetic administration, expanding the ...
InflaRx intends to engage with EMA regarding both vilobelimab and izicopan to evaluate the regulatory path to approval in ANCA-associated ...
Loss of copayment assistance for drugs to treat neovascular age-related macular degeneration forces patients onto alternative, potentially less effective treatment strategies. Patients who switched to ...
Aprepitant Injectable Emulsion has not been studied for the treatment of established nausea and vomiting. Chemotherapy is often a debilitating experience that takes an overwhelming physical, emotional ...
Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for autoimmune and rare diseases, today ...
The FDA approved Lumvoa, a full insulin-like growth factor 1 receptor antagonist, for the treatment of thyroid eye disease, ...
Eli Lilly hits a 52-week high on retatrutide, Mounjaro & Kisunla growth, but valuation and Omvoh demand prompt a Hold rating.
Family alleges treatment error left toddler blind as authorities investigate suspected medical negligence at government ...
South Africa’s rollout of the twice-yearly HIV prevention injection lenacapavir could transform the fight against HIV, but ...
Bermuda Cancer and Health Centre [BCHC] has launched Contrast-Enhanced Mammography [CEM], the first healthcare provider on ...
Free weight-loss jabs will be offered via smartphones, gyms and pharmacies under a radical new government deal. More than 100 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results